Gene sequencing technology, initially semi-automated in the 1980’s, is rapidly advancing to support cutting-edge exploration into disease diagnostics and therapeutic intervention. With the ability to sequence millions of DNA segments in a single run and identify diagnostic markers for multiple species in a sample — without cloning or PCR amplification — sequencing technologies are on the cusp of a new generation. Coined “third gen,” the race for genomics tool suppliers to develop faster more cost-effective sequencing instruments is fueled by a global mission to reduce the cost of sequencing the human genome to under $1,000 US dollars. Cheaper and faster are the keywords in sequencing innovation. But new technologies don’t necessarily render old ones obsolete, as the early sequencing techniques (e.g., Sanger) still present the best solution for specific applications.
This study will explore market analytics:
- Adoption projections for users of NGS technology
- Technology drivers
- Market share by brand of NGS platform
- Sources of funding
- Primary research application(s)
- Unmet current and future NGS technology needs
- …and more!
This study will also explore brand analytics:
- Brand awareness of NGS instrument brands
- Brand comparisons
- Purchasing drivers
- Satisfaction levels with NGS platform attributes
- Willingness to recommend
- Most popular NGS provider
- …and more!